These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9565633)

  • 1. Exogenously provided peptides of a self-antigen can be processed into forms that are recognized by self-T cells.
    Barlow AK; He X; Janeway C
    J Exp Med; 1998 May; 187(9):1403-15. PubMed ID: 9565633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
    Agrawal B; Manickasundari M; Fraga E; Singh B
    J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
    Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
    J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The I-Ab-restricted alloresponse of D10.G4.1 T cells is based on the recognition of an endogenous peptide.
    Gradehandt G; Kleber N; Mattner F; Milbradt S; Rüde E
    Immunology; 1993 Apr; 78(4):592-9. PubMed ID: 8495978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses to self peptides naturally presented by murine class II major histocompatibility complex molecules.
    Rider BJ; Fraga E; Yu Q; Singh B
    Mol Immunol; 1996; 33(7-8):625-33. PubMed ID: 8760274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.
    Guéry JC; Sette A; Appella E; Adorini L
    J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.
    Moreno J; Vignali DA; Nadimi F; Fuchs S; Adorini L; Hämmerling GJ
    J Immunol; 1991 Nov; 147(10):3306-13. PubMed ID: 1658143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody detection of a major self peptide. MHC class II complex.
    Murphy DB; Rath S; Pizzo E; Rudensky AY; George A; Larson JK; Janeway CA
    J Immunol; 1992 Jun; 148(11):3483-91. PubMed ID: 1375245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response.
    Ridgway WM; Ito H; Fassò M; Yu C; Fathman CG
    J Exp Med; 1998 Dec; 188(12):2267-75. PubMed ID: 9858513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class II MHC antigen processing in immune tolerance and inflammation.
    Jurewicz MM; Stern LJ
    Immunogenetics; 2019 Mar; 71(3):171-187. PubMed ID: 30421030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct binding of a synthetic multichain polypeptide to class II major histocompatibility complex molecules on antigen-presenting cells and stimulation of a specific T-cell line require processing of the polypeptide.
    Zisman E; Sela M; Mozes E
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9738-42. PubMed ID: 1946395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides.
    Benichou G; Takizawa PA; Ho PT; Killion CC; Olson CA; McMillan M; Sercarz EE
    J Exp Med; 1990 Nov; 172(5):1341-6. PubMed ID: 1700053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction.
    Fairchild PJ; Wildgoose R; Atherton E; Webb S; Wraith DC
    Int Immunol; 1993 Sep; 5(9):1151-8. PubMed ID: 7694643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of self antigenic determinants: implications for tolerance and autoimmunity.
    Mamula MJ; Craft J
    Curr Opin Immunol; 1994 Dec; 6(6):882-6. PubMed ID: 7536009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unresponsiveness to a foreign antigen can be caused by self-tolerance.
    Vidović D; Matzinger P
    Nature; 1988 Nov; 336(6196):222-5. PubMed ID: 3143074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the MHC-peptide matrix of central tolerance in the human thymus.
    Adamopoulou E; Tenzer S; Hillen N; Klug P; Rota IA; Tietz S; Gebhardt M; Stevanovic S; Schild H; Tolosa E; Melms A; Stoeckle C
    Nat Commun; 2013; 4():2039. PubMed ID: 23783831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the complexity of self.
    Rudensky AYu ; Rath S; Preston-Hurlburt P; Murphy DB; Janeway CA
    Nature; 1991 Oct; 353(6345):660-2. PubMed ID: 1656278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.
    Chornoguz O; Gapeev A; O'Neill MC; Ostrand-Rosenberg S
    Mol Cell Proteomics; 2012 Nov; 11(11):1457-67. PubMed ID: 22942358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engagement of the B lymphocyte antigen receptor induces presentation of intrinsic immunoglobulin peptides on major histocompatibility complex class II molecules.
    Bartnes K; Hannestad K
    Eur J Immunol; 1997 May; 27(5):1124-30. PubMed ID: 9174601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.